tiprankstipranks
Trending News
More News >
Enliven Therapeutics (ELVN)
NASDAQ:ELVN
US Market
Advertisement

Enliven Therapeutics (ELVN) Similar Stocks

Compare
302 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
Enliven Therapeutics
$20.61
$1.22B
-10.30
-28.46%
8 Buy
0 Hold
0 Sell
Strong Buy
Sarepta Therapeutics
$22.81
$2.23B
-30.07
-82.61%
6 Buy
13 Hold
5 Sell
Hold
Viridian Therapeutics
$22.16
$1.81B
-5.20
-3.86%
13 Buy
1 Hold
0 Sell
Strong Buy
Cidara Therapeutics
$93.12
$2.36B
-8.36
639.05%
8 Buy
0 Hold
0 Sell
Strong Buy
Intellia Therapeutics
$25.60
$2.75B
-5.46
60.50%
17 Buy
1 Hold
0 Sell
Strong Buy
AbCellera Biologics
$5.66
$1.69B
-10.13
108.09%
6 Buy
1 Hold
0 Sell
Strong Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
ELVN
Enliven Therapeutics
20.61
-8.05
-28.09%
SRPT
Sarepta Therapeutics
22.81
-107.45
-82.49%
VRDN
Viridian Therapeutics
22.16
-1.12
-4.81%
CDTX
Cidara Therapeutics
93.12
80.65
646.75%
NTLA
Intellia Therapeutics
25.60
9.26
56.67%
ABCL
AbCellera Biologics
5.66
2.77
95.85%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis